Search results for: “biopharmaceutical”
-
Ipsen agrees to acquire Albireo in a $952 million deal
•
PARIS, FRANCE: Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic…
-
Indivior to acquire Opiant Pharmaceuticals for an upfront price of $145mn
•
RICHMOND, VA: Indivior PLC (LON: INDV) and Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) have entered into a definitive agreement…
-
Imophoron Limited appoints Richard Bungay as Chief Executive Officer
•
BRISTOL, UK: Imophoron Limited, a biopharmaceutical company developing novel, next generation nanoparticle products using its ADDomer™ platform, today…
-
Telix Pharmaceuticals acquires Optimal Tracers
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire…
-
Arix Bioscience’s portfolio company Imara Inc to merge with Enliven Therapeutics
•
LONDON, UK: Arix Bioscience plc (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology…
-
Neurocrine Biosciences will acquire Diurnal Group for £48.3 million
•
LONDON, UK: Neurocrine Biosciences will acquire the entire issued and to be issued ordinary share capital of Diurnal…
-
GSK completes $2.6bn acquisition of Affinivax Inc.
•
LONDON: GSK plc (LSE: GSK) has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based…
-
Disc Medicine Inc to merge with Gemini Therapeutics
•
LONDON, UK: Disc Medicine Inc. has entered into a definitive agreement to merge with Gemini Therapeutics Inc. (Nasdaq:…
-
GSK to acquire Affinivax Inc. in a multi-billion dollar deal
•
LONDON, UK: GSK plc (LSE: GSK) has entered into a definitive agreement to acquire Affinivax Inc., a clinical-stage…
-
GSK agrees to acquire Sierra Oncology for $1.9bn
•
LONDON, UK: GlaxoSmithKline plc (LSE: GSK) and Sierra Oncology Inc (Nasdaq: SRRA) have entered into an agreement under…
-
Pfizer to acquire ResApp Health Limited for A$100mn
•
BRISBANE, AUSTRALIA: ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and…
-
Neurotech International appoints Dr Alexandra Andrews as Chief Executive Officer
•
SYDNEY, AUSTRALIA: Neurotech International Limited (ASX: NTI) announced the appointment of Dr Alexandra Andrews as Chief Executive Officer,…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.